CG
KRTX

Cutler Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Cutler Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,500
Closed -$33K – 5465
2022
Q3 		$33K Buy
+1,500
New +$304K ﹤0.01% 2227
2020
Q4 		– Sell
-300
Closed -$1K – 5667
2020
Q3 		$1K Sell
300
-8,500
-97% -$724K ﹤0.01% 4517
2020
Q2 		$14K Sell
8,800
-3,400
-28% -$296K ﹤0.01% 2653
2020
Q1 		$167K Buy
+12,200
New +$1.04M 0.01% 1066

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Cutler Group's KRTX Position: Q1 2024 in Review

Cutler Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 300 shares — an estimated $94K sold.

Cutler Group first reported a position in KRTX in Q1 2020 and held it in 6 quarters. The position peaked at $468K in Q1 2020. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Cutler Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 300 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $94K.
  • Cutler Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 6 quarters.
  • Cutler Group's Karuna Therapeutics, Inc. Common Stock position peaked at $468K in Q1 2020.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.